SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic

被引：8

作者：

Kassir, R. ^{[1
]}

Rebibo, L. ^{[2
,3
]}

Genser, L. ^{[4
]}

Sterkers, A. ^{[5
]}

Blanchet, M. -C. ^{[6
]}

Pattou, F. ^{[7
,8
]}

Msika, S. ^{[2
,3
]}

Abittan, R. ^{[9
]}

Abou-Mrad, A. ^{[10
]}

Arnalsteen, L. ^{[11
]}

Arnoux, R. ^{[12
]}

Auguste, T. ^{[13
]}

Benchetrit, S. ^{[14
]}

Berthet, B. ^{[15
]}

Bertrand, J. -C. ^{[16
]}

Blanchard, L. -C. ^{[17
]}

Bouillot, J. -L. ^{[18
]}

Caiazzo, R. ^{[19
]}

Catheline, J. -M. ^{[18
,20
]}

Chevallier, J. -M. ^{[21
]}

Dargent, J. ^{[22
]}

Fournier, P. ^{[23
]}

Frering, V. ^{[24
]}

Gugenheim, J. ^{[25
]}

Johanet, H. ^{[26
]}

Lechaux, D. ^{[27
]}

Leyre, P. ^{[28
]}

Liagre, A. ^{[29
]}

Mouiel, J. ^{[30
]}

Nocca, D. ^{[31
]}

Pourcher, G. ^{[32
]}

Reche, F. ^{[33
]}

Robert, M. ^{[34
]}

Sebbag, H. ^{[35
]}

Sodji, M. ^{[36
]}

Tuyeras, G. ^{[37
]}

Zimmermann, J. -M. ^{[38
]}

机构：

[1] CHU Reunion, Hop Felix Guyon, Serv Chirurg Digest & Bariatr, La Reunion, France

[2] Hop Bichat Claude Bernard, Serv Chirurg Digest Oesogastr & Bariat, Paris, France

[3] Univ Paris, INSERM, UMR 1149, F-75018 Paris, France

[4] Sorbonne Univ, Hop Univ, AP HP, Serv Chirurg Digest Hepatobiliopancreat & Transpl, Paris, France

[5] Ctr Hosp Prive St Gregoire, Serv Chirurg Digest & Hepatobiliaire, St Gregoire, France

[6] CSO Sauvegarde Lyon, Ctr Lyonnais Chirurg Digest, Lyon, France

[7] CHU Lille, Serv Chirurg Gen & Endocrinienne, Lille, France

[8] Univ Lille, CHU Lille, Lille Pasteur Inst, INSERM,EGID,U1190, Lille, France

[9] Clin Andalouss, Serv Chirurg Digest, Casablanca, Morocco

[10] CHR Orleans, Serv Chirurg Digest Endocrinienne & Thorac, Orleans, France

[11] Hop Prive Louviere, Serv Chirurg Digest, Lille, France

[12] Polyclin Bordeaux, Serv Chirurg Digest, Bordeaux, France

[13] Clin Oceane, Serv Chirurg Digest, Vanne, France

[14] Ctr Obes, Serv Chirurg Digest, Lyon, France

[15] Hop Conception, Serv Chirurg Digest, AP HM, Marseille, France

[16] Inst Arnault Tzanck, Dept Chirurg Viscerale, St Laurent Du Var, France

[17] CHU Nantes, Inst Malad Appareil Digestif, Clin Chirurg Cancerol Digest & Endocrinienne, Nantes, France

[18] Hop Paris St Joseph, Serv Chirurg Digest & Obes, Paris, France

[19] CHU Lille, Lille, France

[20] Ctr Hosp St Denis, Serv Chirurg Digest, St Denis, France

[21] Hop Europeen Georges Pompidou, AP HP, Serv Chirurg Digest Oncol & Bariatr, Paris, France

[22] Polyclin Lyon Nord, Serv Chirurg Bariatr, Rillieux La Pape, France

[23] CHU Vaudois, Serv Chirurg Viscerale, Lausanne, Switzerland

[24] CSO Sauvegarde Lyon, Ctr Lyonnais Chirurg Digest, Lyon, France

[25] CHU Nice, Hop Archet 2, Serv Chirurg Digest & Transplantat Hepat, Nice, France

[26] Clin Turin, Serv Chirurg Digest, Paris, France

[27] Hop Prive Cotes Armor, Serv Chirurg Digest, Plerin, France

[28] Hop Prive Casamance, Serv Chirurg Digest, Aubagne, France

[29] Clin Cedres, Serv Chirurg Bariatr, Cornebarrieu, France

[30] Clin St George, Ctr Obes, Nice, France

[31] CHU St Eloi, Serv Chirurg Digest, Montpellier, France

[32] Inst Mutualiste Montsouris, Ctr Obes, Serv Pathol Digest, Paris, France

[33] CHU Grenoble Alpes, Serv Chirurg Digest, Grenoble, France

[34] Hop Edouard Herriot, Hosp Civils Lyon, Serv Chirurg Digest & Bariatr, Lyon, France

[35] Hop Prive Provence, Serv Chirurg Viscerale & Digest, Aix En Provence, France

[36] Clin Emailleurs, Serv Chirurg Digest, Limoges, France

[37] CHU Toulouse, Serv Chirurg Gen & Digest, Toulouse, France

[38] Hop Prive Residence Parc, Serv Chirurg Digest, Marseille, France

来源：

JOURNAL OF VISCERAL SURGERY | 2020年 / 157卷 / 04期

关键词：

Bariatric surgery; Covid-19; Pandemic; Guidelines; Obesity; Y-GASTRIC BYPASS; LAPAROSCOPIC SLEEVE GASTRECTOMY; MORTALITY; RISK; OUTCOMES; ASSOCIATION; REDUCTION; FISTULA;

D O I：

10.1016/j.jviscsurg.2020.06.005

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Bariatric/metabolic surgery was paused during the Covid-19 pandemic. The impact of social confinement and the interruption of this surgery on the population with obesity has been underestimated, with weight gain and worsened comorbidities. Some candidates for this surgery are exposed to a high risk of mortality linked to the pandemic. Obesity and diabetes are two major risk factors for severe forms of Covid-19. The only currently effective treatment for obesity is metabolic surgery, which confers prompt, lasting benefits. It is thus necessary to resume such surgery. To ensure that this resumption is both gradual and well-founded, we have devised a priority ranking plan. The flow charts we propose will help centres to identify priority patients according to a benefit/risk assessment. Diabetes holds a central place in the decision tree. Resumption patterns will vary from one centre to another according to human, physical and medical resources, and will need adjustment as the epidemic unfolds. Specific informed consent will be required. Screening of patients with obesity should be considered, based on available knowledge. If Covid-19 is suspected, surgery must be postponed. Emphasis must be placed on infection control measures to protect patients and healthcare professionals. Confinement is strongly advocated for patients for the first month post-operatively. Patient follow-up should preferably be by teleconsultation. (C) 2020 Elsevier Masson SAS. All rights reserved.

引用

页码：317 / 327

页数：11

共 28 条

[1] Agence nationale de securite sanitaire de l'alimentation de l'environnement et du travail., 2020, AV REL EV RISQ LIES
[2] [Anonymous], 2015, OBES SURG, DOI DOI 10.1007/S11695-015-1822-4
[3] [Anonymous], 2020, NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STATE NEW YORK TIMES STA
[4] Obesity Surgery Score (OSS) for Prioritization in the Bariatric Surgery Waiting List: a Need of Public Health Systems and a Literature Review
Casimiro Perez, Jose Antonio
Fernandez Quesada, Carlos
Groba Marco, Maria del Val
Arteaga Gonzalez, Ivan
Cruz Benavides, Francisco
Ponce, Jaime
de Pablos Velasco, Pedro
Marchena Gomez, Joaquin
[J]. OBESITY SURGERY, 2018, 28 (04) : 1175 - 1184
[5] Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass
DeMaria, Eric J.
Portenier, Dana
Wolfe, Luke
[J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2007, 3 (02) : 134 - 140
[6] 30-Day Outcomes of Revisional Bariatric Stapling Procedures: First Report Based on MBSAQIP Data Registry
El Chaar, Maher
Stoltzfus, Jill
Melitics, Maureen
Claros, Leonardo
Zeido, Ahmad
[J]. OBESITY SURGERY, 2018, 28 (08) : 2233 - 2240
[7] Years of life lost due to obesity
Fontaine, KR
Redden, DT
Wang, CX
Westfall, AO
Allison, DB
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (02): : 187 - 193
[8] Combining risk estimates from observational studies with different exposure cutpoints: A meta-analysis on body mass index and diabetes type 2
Hartemink, Nienke
Boshuizen, Hendriek C.
Nagelkerke, Nico J. D.
Jacobs, Monique A. M.
van Houwelingen, Hans C.
[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : 1042 - 1052
[9] Association of Bariatric Surgery vs Medical Obesity Treatment With Long- term Medical Complications and Obesity- Related Comorbidities
Jakobsen, Gunn Signe
Smastuen, Milada Cvancarova
Sandbu, Rune
Nordstrand, Njord
Hofso, Dag
Lindberg, Morten
Hertel, Jens Kristoffer
Hjelmesaeth, Joran
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (03): : 291 - 301
[10] Revisional Bariatric Surgery in Israel: Findings from the Israeli Bariatric Surgery Registry
Keren, D.
Romano-Zelekha, O.
Rainis, T.
Sakran, N.
[J]. OBESITY SURGERY, 2019, 29 (11) : 3514 - 3522

← 1 2 3 →